Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 981


Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results from a Large Multicenter Trial.

Thompson JF, Haydu LE, Uren RF, Andtbacka RH, Zager JS, Beitsch PD, Agnese DM, Mozzillo N, Testori A, Bowles TL, Hoekstra HJ, Kelley MC, Sussman J, Schneebaum S, Smithers BM, McKinnon G, Hsueh E, Jacobs L, Schultz E, Reintgen D, Kane JM, Friedman EB, Wang H, Van Kreuningen L, Schiller V, Elashoff DA, Elashoff R, Cochran AJ, Stern S, Faries MB; MSLT-II Trial Group.

Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003405. [Epub ahead of print]


Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial.

Long GV, Saw RPM, Lo S, Nieweg OE, Shannon KF, Gonzalez M, Guminski A, Lee JH, Lee H, Ferguson PM, Rawson RV, Wilmott JS, Thompson JF, Kefford RF, Ch'ng S, Stretch JR, Emmett L, Kapoor R, Rizos H, Spillane AJ, Scolyer RA, Menzies AM.

Lancet Oncol. 2019 Jun 3. pii: S1470-2045(19)30331-6. doi: 10.1016/S1470-2045(19)30331-6. [Epub ahead of print]


LNK suppresses interferon signaling in melanoma.

Ding LW, Sun QY, Edwards JJ, Fernández LT, Ran XB, Zhou SQ, Scolyer RA, Wilmott JS, Thompson JF, Doan N, Said JW, Venkatachalam N, Xiao JF, Loh XY, Pein M, Xu L, Mullins DW, Yang H, Lin DC, Koeffler HP.

Nat Commun. 2019 May 20;10(1):2230. doi: 10.1038/s41467-019-09711-y.


Multidisciplinary care of cancer patients: a passing fad or here to stay?

Thompson JF, Williams GJ.

ANZ J Surg. 2019 May;89(5):464-465. doi: 10.1111/ans.15138. No abstract available.


Clinical importance and surgical management of sentinel lymph nodes in the popliteal fossa of melanoma patients.

Nijhuis AAG, de A O Santos Filho ID, Uren RF, Thompson JF, Nieweg OE.

Eur J Surg Oncol. 2019 Mar 23. pii: S0748-7983(19)30354-3. doi: 10.1016/j.ejso.2019.03.026. [Epub ahead of print]


Re: "Time to Reconsider the Role of Sentinel Lymph Node Biopsy in Melanoma".

Faries MB, Cochran AJ, Thompson JF.

J Am Acad Dermatol. 2019 Mar 27. pii: S0190-9622(19)30508-0. doi: 10.1016/j.jaad.2019.03.064. [Epub ahead of print] No abstract available.


Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.

Miura JT, Kroon HM, Beasley GM, Mullen D, Farrow NE, Mosca PJ, Lowe MC, Farley CR, Kim Y, Naqvi SMH, Potdar A, Daou H, Sun J, Farma JM, Henderson MA, Speakman D, Serpell J, Delman KA, Mark Smithers B, Coventry BJ, Tyler DS, Thompson JF, Zager JS.

Ann Surg Oncol. 2019 Mar 25. doi: 10.1245/s10434-019-07288-w. [Epub ahead of print]


False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma.

Nijhuis AAG, Dieng M, Khanna N, Lord SJ, Dalton J, Menzies AM, Turner RM, Allen J, Saw RPM, Nieweg OE, Thompson JF, Morton RL.

Ann Surg Oncol. 2019 Jun;26(6):1860-1868. doi: 10.1245/s10434-019-07311-0. Epub 2019 Mar 25.


Embracing changes to the American Joint Committee on Cancer 8th edition melanoma staging system.

Haydu LE, Thompson JF, Scolyer RA, Gershenwald JE.

Eur J Cancer. 2019 May;112:9-11. doi: 10.1016/j.ejca.2019.01.103. Epub 2019 Mar 15. No abstract available.


Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study.

Kroon HM, Coventry BJ, Henderson MA, Barbour A, Serpell J, Smithers BM, Thompson JF.

Eur J Surg Oncol. 2019 May;45(5):832-837. doi: 10.1016/j.ejso.2019.02.026. Epub 2019 Feb 27.


Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an international study from 17 centers.

Dessinioti C, Dimou N, Geller AC, Stergiopoulou A, Lo S, Keim U, Gershenwald JE, Haydu LE, Ribero S, Quaglino P, Puig S, Malvehy J, Kandolf-Sekulovic L, Radevic T, Kaufmann R, Meister L, Nagore E, Traves V, Champsas GG, Plaka M, Dreno B, Varey E, Ramirez DM, Dummer R, Mangana J, Hauschild A, Egberts F, Peris K, Del Regno L, Forsea AM, Zurac SA, Vieira R, Brinca A, Zalaudek I, Deinlein T, Linos E, Evangelou E, Thompson JF, Scolyer RA, Garbe C, Stratigos AJ.

J Natl Cancer Inst. 2019 Mar 13. pii: djz034. doi: 10.1093/jnci/djz034. [Epub ahead of print]


Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients.

Lee JH, Saw RP, Thompson JF, Lo S, Spillane AJ, Shannon KF, Stretch JR, Howle J, Menzies AM, Carlino MS, Kefford RF, Long GV, Scolyer RA, Rizos H.

Ann Oncol. 2019 May 1;30(5):815-822. doi: 10.1093/annonc/mdz075.


Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas.

Quek C, Rawson RV, Ferguson PM, Shang P, Silva I, Saw RPM, Shannon K, Thompson JF, Hayward NK, Long GV, Mann GJ, Scolyer RA, Wilmott JS.

Oncotarget. 2019 Jan 29;10(9):930-941. doi: 10.18632/oncotarget.26584. eCollection 2019 Jan 29.


Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-naïve Melanoma Patients: Implications for Clinical Trials.

Edwards J, Tasker A, Pires da Silva I, Quek C, Batten M, Ferguson A, Allen R, Allanson B, Saw RPM, Thompson JF, Menzies AM, Palendira U, Wilmott JS, Long GV, Scolyer RA.

Clin Cancer Res. 2019 Jun 1;25(11):3247-3258. doi: 10.1158/1078-0432.CCR-18-4011. Epub 2019 Feb 18.


Molecular Genomic Profiling of Melanocytic Nevi.

Colebatch AJ, Ferguson P, Newell F, Kazakoff SH, Witkowski T, Dobrovic A, Johansson PA, Saw RPM, Stretch JR, McArthur GA, Long GV, Thompson JF, Pearson JV, Mann GJ, Hayward NK, Waddell N, Scolyer RA, Wilmott JS.

J Invest Dermatol. 2019 Feb 14. pii: S0022-202X(19)30118-6. doi: 10.1016/j.jid.2018.12.033. [Epub ahead of print]


Quality of Life Following Surgical Excision of Early-Stage Melanoma of the Head and Neck.

Thompson JF, Lo S, Scolyer RA.

JAMA Dermatol. 2019 Feb 13. doi: 10.1001/jamadermatol.2018.5742. [Epub ahead of print] No abstract available.


Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy.

Gide TN, Quek C, Menzies AM, Tasker AT, Shang P, Holst J, Madore J, Lim SY, Velickovic R, Wongchenko M, Yan Y, Lo S, Carlino MS, Guminski A, Saw RPM, Pang A, McGuire HM, Palendira U, Thompson JF, Rizos H, Silva IPD, Batten M, Scolyer RA, Long GV, Wilmott JS.

Cancer Cell. 2019 Feb 11;35(2):238-255.e6. doi: 10.1016/j.ccell.2019.01.003.


ASO Author Reflections: Subungual Melanomas of the Hand Present Diagnostic and Therapeutic Challenges.

Chakera AH, Thompson JF.

Ann Surg Oncol. 2019 Apr;26(4):1044-1045. doi: 10.1245/s10434-019-07196-z. Epub 2019 Feb 4. No abstract available.


Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients.

Lee H, Quek C, Silva I, Tasker A, Batten M, Rizos H, Lim SY, Nur Gide T, Shang P, Attrill GH, Madore J, Edwards J, Carlino MS, Guminski A, Saw RPM, Thompson JF, Ferguson PM, Palendira U, Menzies AM, Long GV, Scolyer RA, Wilmott JS.

Oncoimmunology. 2018 Oct 31;8(2):e1537581. doi: 10.1080/2162402X.2018.1537581. eCollection 2019.


The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma.

Zhao X, Little P, Hoyle AP, Pegna GJ, Hayward MC, Ivanova A, Parker JS, Marron DL, Soloway MG, Jo H, Salazar AH, Papakonstantinou MP, Bouchard DM, Jefferys SR, Hoadley KA, Ollila DW, Frank JS, Thomas NE, Googe PB, Ezzell AJ, Collichio FA, Lee CB, Earp HS, Sharpless NE, Hugo W, Wilmott JS, Quek C, Waddell N, Johansson PA, Thompson JF, Hayward NK, Mann GJ, Lo RS, Johnson DB, Scolyer RA, Hayes DN, Moschos SJ.

Front Oncol. 2019 Jan 4;8:584. doi: 10.3389/fonc.2018.00584. eCollection 2018.


Methods of melanoma detection and of skin monitoring for individuals at high risk of melanoma: new Australian clinical practice.

Adler NR, Kelly JW, Guitera P, Menzies SW, Chamberlain AJ, Fishburn P, Button-Sloan AE, Heal C, Soyer HP, Thompson JF.

Med J Aust. 2019 Jan;210(1):41-47. doi: 10.5694/mja2.12033. Epub 2018 Dec 2.


Sentinel lymph node biopsy for in situ melanoma is unlikely in Australia.

Morton RL, Thompson JF.

BMJ Qual Saf. 2019 Mar;28(3):253-254. doi: 10.1136/bmjqs-2018-009138. Epub 2019 Jan 3. No abstract available.


Inter- and intrapatient heterogeneity of indoleamine 2,3-dioxygenase expression in primary and metastatic melanoma cells and the tumour microenvironment.

Gide TN, Allanson BM, Menzies AM, Ferguson PM, Madore J, Saw RPM, Thompson JF, Long GV, Wilmott JS, Scolyer RA.

Histopathology. 2019 May;74(6):817-828. doi: 10.1111/his.13814.


Subungual Melanoma of the Hand.

Chakera AH, Quinn MJ, Lo S, Drummond M, Haydu LE, Bond JS, Stretch JR, Saw RPM, Lee KJ, McCarthy WH, Scolyer RA, Thompson JF.

Ann Surg Oncol. 2019 Apr;26(4):1035-1043. doi: 10.1245/s10434-018-07094-w. Epub 2018 Dec 18.


RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomes.

Guo D, Lui GYL, Lai SL, Wilmott JS, Tikoo S, Jackett LA, Quek C, Brown DL, Sharp DM, Kwan RYQ, Chacon D, Wong JH, Beck D, van Geldermalsen M, Holst J, Thompson JF, Mann GJ, Scolyer RA, Stow JL, Weninger W, Haass NK, Beaumont KA.

Int J Cancer. 2019 Jun 15;144(12):3070-3085. doi: 10.1002/ijc.32064. Epub 2019 Jan 3.


Primary anorectal melanoma: clinical, immunohistology and DNA analysis of 43 cases.

Dodds TJ, Wilmott JS, Jackett LA, Lo SN, Long GV, Thompson JF, Scolyer RA.

Pathology. 2019 Jan;51(1):39-45. doi: 10.1016/j.pathol.2018.09.060. Epub 2018 Nov 26.


Management of Regional Lymph Nodes in Patients with Merkel Cell Carcinoma Following a Positive Sentinel Node Biopsy: Less May be More, But is Either Enough?

Hruby G, Guminski A, Thompson JF.

Ann Surg Oncol. 2019 Feb;26(2):315-317. doi: 10.1245/s10434-018-7076-3. Epub 2018 Nov 27. No abstract available.


Isolated Limb Infusion and Isolated Limb Perfusion for Melanoma: Can the Outcomes of these Procedures be Compared?

Kroon HM, Thompson JF.

Ann Surg Oncol. 2019 Jan;26(1):8-9. doi: 10.1245/s10434-018-7067-4. Epub 2018 Nov 21. No abstract available.


Letter re: Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma: A multicenter experience.

Kroon HM, Thompson JF.

Eur J Surg Oncol. 2019 Jun;45(6):1121. doi: 10.1016/j.ejso.2018.10.544. Epub 2018 Nov 2. No abstract available.


ASO Author Reflections: Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas.

Thompson JF, Scolyer RA, Lo SN.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):918-919. doi: 10.1245/s10434-018-7014-4. Epub 2018 Nov 9. No abstract available.


Epigenetic profiling for the molecular classification of metastatic brain tumors.

Orozco JIJ, Knijnenburg TA, Manughian-Peter AO, Salomon MP, Barkhoudarian G, Jalas JR, Wilmott JS, Hothi P, Wang X, Takasumi Y, Buckland ME, Thompson JF, Long GV, Cobbs CS, Shmulevich I, Kelly DF, Scolyer RA, Hoon DSB, Marzese DM.

Nat Commun. 2018 Nov 6;9(1):4627. doi: 10.1038/s41467-018-06715-y.


ASO Author Reflections: Limited Surgery Plus Radiotherapy for Melanoma Patients with Cervical Node Metastases.

Thompson JF, Kroon HM.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):912-913. doi: 10.1245/s10434-018-6959-7. Epub 2018 Oct 26. No abstract available.


Correlation Between Surgical and Histologic Margins in Melanoma Wide Excision Specimens.

Friedman EB, Dodds TJ, Lo S, Ferguson PM, Beck M, Saw RPM, Stretch JR, Lee KK, Nieweg OE, Spillane AJ, Scolyer RA, Thompson JF.

Ann Surg Oncol. 2019 Jan;26(1):25-32. doi: 10.1245/s10434-018-6858-y. Epub 2018 Oct 16.


The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management.

Guitera P, Collgros H, Madronio CM, Goumas C, Mann GJ, Watts CG, Pereira AR, Armstrong BK, Drummond M, Morton RL, Scolyer RA, Menzies SW, Thompson JF, Cust AE.

Australas J Dermatol. 2019 May;60(2):118-125. doi: 10.1111/ajd.12928. Epub 2018 Oct 9.


Sentinel lymph node biopsy remains the most accurate method of obtaining staging and prognostic information for patients with primary cutaneous melanomas.

Friedman EB, Moncrieff MD, Lo S, Scolyer RA, Thompson JF.

Australas J Dermatol. 2019 Feb;60(1):75-76. doi: 10.1111/ajd.12942. Epub 2018 Oct 7. No abstract available.


Comment on "Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma".

Lo SN, Stodell MD, Scolyer RA, Thompson JF.

J Am Acad Dermatol. 2019 Jan;80(1):e21-e22. doi: 10.1016/j.jaad.2018.07.068. Epub 2018 Sep 15. No abstract available.


Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.

Isaksson K, Nielsen K, Mikiver R, Nieweg OE, Scolyer RA, Thompson JF, Ingvar C.

J Surg Oncol. 2018 Sep;118(4):599-605. doi: 10.1002/jso.25208. Epub 2018 Sep 9.


Continuing and new roles for surgery in the management of patients with stage IV melanoma.

Friedman EB, Thompson JF.

Melanoma Manag. 2018 Apr 9;5(1):MMT03. doi: 10.2217/mmt-2017-0024. eCollection 2018 Jun. No abstract available.


Has the melanoma information tsunami become a maelstrom?

Thompson JF, Menzies AM.

Melanoma Manag. 2017 Dec;4(4):179-182. doi: 10.2217/mmt-2017-0020. Epub 2017 Sep 14. No abstract available.


Occupational physical activity in brewery and office workers.

Thompson JF, Severson RL, Rosecrance JC.

J Occup Environ Hyg. 2018 Sep;15(9):686-699. doi: 10.1080/15459624.2018.1492136.


Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.

Wilmott JS, Johansson PA, Newell F, Waddell N, Ferguson P, Quek C, Patch AM, Nones K, Shang P, Pritchard AL, Kazakoff S, Holmes O, Leonard C, Wood S, Xu Q, Saw RPM, Spillane AJ, Stretch JR, Shannon KF, Kefford RF, Menzies AM, Long GV, Thompson JF, Pearson JV, Mann GJ, Hayward NK, Scolyer RA.

Int J Cancer. 2019 Mar 1;144(5):1049-1060. doi: 10.1002/ijc.31791. Epub 2018 Nov 21.


Treatment of Clinically Positive Cervical Lymph Nodes by Limited Local Node Excision and Adjuvant Radiotherapy in Melanoma Patients with Major Comorbidities.

Kroon HM, van der Bol WD, Tonks KT, Hong AM, Hruby G, Thompson JF.

Ann Surg Oncol. 2018 Nov;25(12):3476-3482. doi: 10.1245/s10434-018-6692-2. Epub 2018 Aug 16.


Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis.

Krisp C, Parker R, Pascovici D, Hayward NK, Wilmott JS, Thompson JF, Mann GJ, Long GV, Scolyer RA, Molloy MP.

Br J Cancer. 2018 Sep;119(6):713-723. doi: 10.1038/s41416-018-0227-2. Epub 2018 Aug 17.


When is surgery for metastatic melanoma still the most appropriate treatment option?

Friedman EB, Ferguson PM, Thompson JF.

Expert Rev Anticancer Ther. 2018 Oct;18(10):943-945. doi: 10.1080/14737140.2018.1508346. Epub 2018 Aug 9. No abstract available.


Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction.

Raz L, Bhaskar K, Weaver J, Marini S, Zhang Q, Thompson JF, Espinoza C, Iqbal S, Maphis NM, Weston L, Sillerud LO, Caprihan A, Pesko JC, Erhardt EB, Rosenberg GA.

Neurobiol Dis. 2019 Jun;126:124-136. doi: 10.1016/j.nbd.2018.07.009. Epub 2018 Jul 25. Review.


Recurrent heteroplasmy for the MT-ATP6 p.Ser148Asn (m.8969G>A) mutation in patients with syndromic congenital sideroblastic anemia of variable clinical severity.

Berhe S, Heeney MM, Campagna DR, Thompson JF, White EJ, Ross T, Peake RWA, Hanrahan JD, Rodriguez V, Renaud DL, Patnaik MS, Chang E, Bottomley SS, Fleming MD.

Haematologica. 2018 Dec;103(12):e561-e563. doi: 10.3324/haematol.2018.199109. Epub 2018 Jul 13. No abstract available.


Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.

Moncrieff MD, Gyorki D, Saw R, Spillane AJ, Thompson JF, Peach H, Oudit D, Geh J, Dziewulsk P, Wilson E, Matteucci P, Pritchard-Jones R, Olofsson Bagge R, Wright FC, Crampton N, Cassell O, Jallali N, Berger A, Kelly J, Hamilton S, Durrani A, Lo S, Paton E, Henderson MA.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):991. doi: 10.1245/s10434-018-6612-5.


MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.

Dreno B, Thompson JF, Smithers BM, Santinami M, Jouary T, Gutzmer R, Levchenko E, Rutkowski P, Grob JJ, Korovin S, Drucis K, Grange F, Machet L, Hersey P, Krajsova I, Testori A, Conry R, Guillot B, Kruit WHJ, Demidov L, Thompson JA, Bondarenko I, Jaroszek J, Puig S, Cinat G, Hauschild A, Goeman JJ, van Houwelingen HC, Ulloa-Montoya F, Callegaro A, Dizier B, Spiessens B, Debois M, Brichard VG, Louahed J, Therasse P, Debruyne C, Kirkwood JM.

Lancet Oncol. 2018 Jul;19(7):916-929. doi: 10.1016/S1470-2045(18)30254-7. Epub 2018 Jun 13.


1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.

Moncrieff MD, Gyorki D, Saw R, Spillane AJ, Thompson JF, Peach H, Oudit D, Geh J, Dziewulski P, Wilson E, Matteucci P, Pritchard-Jones R, Olofsson Bagge R, Wright FC, Crampton N, Cassell O, Jallali N, Berger A, Kelly J, Hamilton S, Durrani A, Lo S, Paton E, Henderson MA.

Ann Surg Oncol. 2018 Sep;25(9):2541-2549. doi: 10.1245/s10434-018-6470-1. Epub 2018 May 30. Erratum in: Ann Surg Oncol. 2018 Jun 26;:. Thompson JF [added].


The role of sentinel lymph node biopsy as a staging procedure in patients with melanoma - A critical appraisal.

Nieweg OE, Cooper A, Thompson JF.

Australas J Dermatol. 2018 Aug;59(3):235-236. doi: 10.1111/ajd.12839. Epub 2018 May 11. No abstract available.


Supplemental Content

Loading ...
Support Center